Effects of human recombinant alpha-2b interferon and feline recombinant omega interferon on in vitro replication of feline herpesvirus-1

American Journal of Veterinary Research

Volumn 67, Issue 8, 2006, Pages 1406-1411

  Siebeck, Nicola ^a,c   Hurley, David J ^a   Garcia, Maricarmen ^a   Greene, Craig E ^a   Köstlin, Roberto G ^b   Moore, Phillip A ^a   Dietrich, Ursula M ^a  

^a UNIVERSITY OF GEORGIA   (United States)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; RECOMBINANT ALPHA2B INTERFERON; RECOMBINANT INTERFERON; RECOMBINANT INTERFERON OMEGA; UNCLASSIFIED DRUG; VIRBAGEN OMEGA;

ANALYSIS OF VARIANCE; ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CAT DISEASE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; HERPES SIMPLEX VIRUS 1; HUMAN; IN VITRO STUDY; INOCULATION; INTOXICATION; KIDNEY CELL CULTURE; NONHUMAN; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; CATS; HERPESVIRIDAE; HUMANS; INTERFERON ALFA-2B; INTERFERON TYPE I; PLAQUE ASSAY; SPECIES SPECIFICITY; VIRUS REPLICATION;

FELID HERPESVIRUS 1; FELIDAE;

EID: 33747772055     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.67.8.1406     Document Type: Article

References (30)

1. Murphy F, Gibbs P, Horzinek M, et al, eds. Chapter 3: viral replication. In: Veterinary virology. 3rd ed. San Diego: Academic Press Inc, 1999;43-59.
2. Glaze M, Gelatt K. Feline ophthalmology. In: Gelatt KN, ed. Veterinary ophthalmology. 3rd ed. Baltimore: Lippincott, Williams & Wilkins, 1999;997-1017.
3. Stiles J. Feline herpesvirus. Vet Clin North Am Small Anim Pract 2000;30:1001-1014.
4. Andrew SE. Ocular manifestations of feline herpesvirus. J Feline Med Surg 2001;3:9-16.
5. Gaskell RM, Dawson S. Feline respiratory disease. In: Greene CE, ed. Infectious diseases of the dog and cat. 2nd ed. Philadelphia: WB Saunders Co, 1998;97-105.
6. Gaskell RM, Dennis PE, Goddard LE, et al. Isolation of felid herpesvirus I from the trigeminal ganglia of latently infected cats. J Gen Virol 1985;66:391-394.
7. Nasisse MP, Davis BJ, Guy JS, et al. Isolation of feline herpesvirus 1 from the trigeminal ganglia of acutely and chronically infected cats. J Vet Intern Med 1992;6:102-103.
8. Wolf A. Other feline viral diseases. In: Ettinger S, Feldmann EC, eds. Textbook of veterinary internal medicine: diseases of the dog and cat. 5th ed. Philadelphia: WB Saunders Co, 2000;445-448.
9. Gaskell RM, Povey RC. Re-excretion of feline viral rhinotracheitis virus following corticosteroid treatment. Vet Rec 1973;93:204-205.
10. Gaskell RM, Povey RC. Experimental induction of feline viral rhinotracheitis virus re-excretion in FVR-recovered cats. Vet Rec 1977;100:128-133.
11. Neumann-Haefelin D, Sundmacher R, Sauter B, et al. Effect of human leukocyte interferon on vaccinia-and herpes virus-infected cell cultures and monkey corneas. Infect Immun 1975; 12:148-155.
12. McGill JI, Collins P, Cantell K, et al. Optimal schedules for use of interferon in the corneas of rabbits with herpes simplex keratitis. J Infect Dis 1976;133(suppl):A13-A17.
13. Trousdale MD, Robin JB, Stebbing N. Reevaluation of human alpha interferons against herpesvirus infection of the rabbit eye. Curr Eye Res 1987;6:269-272.
14. McLeish W, Pflugfelder SC, Crouse C, et al. Interferon treatment of herpetic keratitis in a patient with acquired immunodeficiency syndrome. Am J Ophthalmol 1990;109:93-95.
15. Minkowitz JB, Pepose JS. Topical interferon alpha-2a treatment of herpes simplex keratitis resistant to multiple antiviral medications in an immunosuppressed patient. Cornea 1995;14:326-330.
16. Sundmacher R, Cantell K, Mattes A. Combination therapy for dendritic keratitis. High-titer alpha-interferon and trifluridine. Arch Ophthalmol 1984;102:554-555.
17. Levin MJ, Leary PL. Inhibition of human herpesviruses by combinations of acyclovir and human leukocyte interferon. Infect Immun 1981;32:995-999.
18. DeKoning EWJ, van Bijsterfeld OP, Cantell K. Combination therapy for dendritic keratitis with acyclovir and interferon. Arch Ophthalmol 1983;101:1866-1868.
19. Taylor J, Punda-Polic V, O'Brien WJ. Combined anti-herpes virus activity of nucleoside analogs and interferon. Curr Eye Res 1991;10(suppl):205-211.
20. Smolin G, Matli M, Okumoto M, et al. Use of recombinant interferon to prevent herpesvirus shedding. Curr Eye Res 1984;3:1069-1074.
21. Fulton RW, Burge LJ. Susceptibility of feline herpesvirus 1 and a feline calicivirus to feline interferon and recombinant human leukocyte interferons. Antimicrob Agents Chemother 1985; 28:698-699.
22. Gould D. The eye. In: Ramsey IK, Tennant BJ, eds. BSAVA manual of canine and feline infectious diseases. Gloucester, England: British Small Animal Veterinary Association, 1998;223-264.
23. Sakurai T, Ueda Y, Sato M, et al. Feline interferon production in silkworm by recombinant baculovirus. J Vet Med Sci 1992;54:563-565.
24. Minagawa T, Ishiwata K, Kajimoto T. Feline interferon-omega treatment on canine parvovirus infection. Vet Microbiol 1999;69:51-53.
25. de Mari K, Maynard L, Sanquer A, et al. Therapeutic effects of recombinant feline interferon-omega on feline leukemia virus (FeLV)-infected and FeLV/feline immunodeficiency virus (FIV)-coinfected symptomatic cats. J Vet Intern Med 2004;18:477-482.
26. Mochizuki M, Nakatani H, Yoshida M. Inhibitory effects of recombinant feline interferon on the replication of feline enteropathogenic viruses in vitro. Vet Microbiol 1994;39:145-152.
27. Weck PK, Apperson S, May L, et al. Comparison of the antiviral activities of various cloned human interferon-alpha subtypes in mammalian cell cultures. J Gen Virol 1981;57:233-237.
28. Fuerst DJ, Math M, Smolin G, et al. Interferon effects on herpes simplex virus in rabbit and human cell cultures. Curr Eye Res 1986;5:331-335.
29. Flint SJ, Enquist LW, Krug RM, et al. III: pathogenesis and control. In: Flint SJ, Enquist LW, Krug RM, et al, eds. Principles of virology: molecular biology, pathogenesis, and control. Washington, DC: American Society for Microbiology Press, 2000;477-515.
30. Zeidner NS, Myles MH, Mathiason-DuBard CK, et al. Alpha interferon (2b) in combination with zidovudine for the treatment of presymptomatic feline leukemia virus-induced immunodeficiency syndrome. Antimicrob Agents Chemother 1990;34:1749-1756.